Christophe E. Redon
- Cancer Research top 0.5%
- Carcinogens and Genotoxicity Assessment 16
- Molecular Biology top 0.5%
- DNA Repair Mechanisms 63
- Cancer therapeutics and mechanisms 29
- Genomics and Chromatin Dynamics 19
- Epigenetics and DNA Methylation 8
- DNA and Nucleic Acid Chemistry 7
- Oncology top 0.5%
- PARP inhibition in cancer therapy 8
- Toxicology top 0.5%
-
- Effects of Radiation Exposure 15
- Co-authors
- William M. BonnerEmmy P. RogakouOlga A. SedelnikovaAsako NakamuraJennifer S. DickeyYves PommierDuane R. PilchOlga A. Martin
- Journals
- Nature Communications (7 papers)Cancer Research (5 papers)Journal of Clinical Oncology (4 papers)
- Partner nations
- United StatesJapanSouth Korea
In The Last Decade
Christophe E. Redon
103 papers receiving 10.6k citations
Hit Papers
Peers
Comparison fields: 5 of 147
- Cancer Research 2.4k
- Molecular Biology 8.4k
- Oncology 2.9k
- Toxicology 213
- Radiology, Nuclear Medicine and Imaging 1.3k
Countries citing papers authored by Christophe E. Redon
This map shows the geographic impact of Christophe E. Redon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christophe E. Redon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christophe E. Redon more than expected).
Fields of papers citing papers by Christophe E. Redon
This network shows the impact of papers produced by Christophe E. Redon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christophe E. Redon. The network helps show where Christophe E. Redon may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Christophe E. Redon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 4 | |
| 2 | 2023 | 5 | |
| 3 | 2022 | 14 | |
| 4 | 2022 | 18 | |
| 5 | 2022 | 16 | |
| 6 | 2021 | 9 | |
| 7 | 2021 | 55 | |
| 8 | 2021 | 24 | |
| 9 | 2020 | 38 | |
| 10 | 2018 | 143 | |
| 11 | 2018 | 182 | |
| 12 | 2016 | 61 | |
| 13 | 2014 | 79 | |
| 14 | 2014 | 5 | |
| 15 | 2010 | 65 | |
| 16 | 2008 | 59 | |
| 17 | A validated assay for gamma-H2AX as a pharmacodynamic biomarker of response to DNA damage | 2007 | 1 |
| 18 | 2007 | 176 | |
| 19 | 2004 | 156 | |
| 20 | 2003 | 249 |
About Christophe E. Redon
Christophe E. Redon is a scholar working on Cancer Research, Molecular Biology and Toxicology, having authored 105 papers that have together received 10.7k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (63 papers), Cancer therapeutics and mechanisms (29 papers), Genomics and Chromatin Dynamics (19 papers), Carcinogens and Genotoxicity Assessment (16 papers), Effects of Radiation Exposure (15 papers), PARP inhibition in cancer therapy (8 papers), Epigenetics and DNA Methylation (8 papers) and DNA and Nucleic Acid Chemistry (7 papers). The work is most often cited by research in Cancer Research (2.4k citations), Molecular Biology (8.4k citations) and Oncology (2.9k citations). Christophe E. Redon has collaborated with scholars based in United States, Japan and South Korea. Frequent co-authors include William M. Bonner, Emmy P. Rogakou, Olga A. Sedelnikova, Asako Nakamura, Jennifer S. Dickey, Yves Pommier, Duane R. Pilch, Olga A. Martin, Stéphanie Solier and Mirit I. Aladjem. Their work appears in journals such as Nature Communications, Cancer Research, Journal of Clinical Oncology, PLoS ONE and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.